Skip Navigation

Badger-founded Constantiam Biosciences secures $2M from the NIH

Constantiam Biosciences is a biotechnology start-up company founded by three Wisconsin grads — Nicholas Schafer ’08, Daniel Goldman ’07, and Norman Ong ’07 — focused on interpreting the vast diversity of human genetic variation to improve outcomes for patients afflicted by cancer, neurodegeneration, and cardiovascular disease. The company has been awarded a $2M Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute (NHGRI) to develop technologies aimed at addressing medically inactionable variants of uncertain significance (VUS) uncovered in clinical genetic tests. Constantiam’s technologies enable classification of VUS to improve patient outcomes across a wide variety of medical conditions, unlocking the power of precision medicine.

More Alumni Notes

Michael Anderson ’05, MS’09, PhD’11 and Jie Liu ’09, MS’11 celebrated 14 years of marriage in November 2025. They met in 2009 while working for different Wisconsin professors at CERN in the city of Meyrin, Switzerland. Michael was a research assis...

Cyber Monday Savings – Shop the UW Alumni Store and save 25% on your entire purchase — today only! Use promo code: UWCYBER25